Cold autoimmune hemolytic anemia: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
== Cold Autoimmune Hemolytic Anemia == | |||
'''Cold Autoimmune Hemolytic Anemia''' (CAHA) is a rare type of [[autoimmune hemolytic anemia]] (AIHA) characterized by the premature destruction of [[red blood cells]] (RBCs) at low temperatures. This condition is mediated by [[autoantibodies]] that bind to RBCs, leading to their destruction by the [[immune system]]. | |||
CAHA is | |||
== Pathophysiology == | |||
In CAHA, the immune system produces [[cold agglutinins]], which are antibodies that react with RBCs at temperatures below normal body temperature, typically between 0°C and 30°C. These antibodies are usually of the [[IgM]] class and can cause RBCs to clump together (agglutinate) and be destroyed, primarily in the [[liver]] and [[spleen]]. | |||
== Symptoms == | == Symptoms == | ||
The symptoms of CAHA can vary | |||
The symptoms of CAHA can vary depending on the severity of the condition and the degree of hemolysis. Common symptoms include: | |||
* [[Fatigue]] | |||
* [[Pallor]] | |||
* [[Jaundice]] | |||
* [[Dark urine]] | |||
* [[Cold-induced acrocyanosis]] | |||
== Diagnosis == | == Diagnosis == | ||
Diagnosis of CAHA | |||
Diagnosis of CAHA involves several laboratory tests, including: | |||
* [[Complete blood count]] (CBC) showing anemia | |||
* [[Direct Coombs test]] (direct antiglobulin test) positive for complement | |||
* Detection of cold agglutinins in the blood | |||
* [[Blood smear]] showing agglutinated RBCs | |||
== Treatment == | == Treatment == | ||
Treatment | |||
Treatment of CAHA focuses on managing symptoms and preventing hemolysis. Strategies include: | |||
* Avoiding exposure to cold temperatures | |||
* Use of [[immunosuppressive drugs]] such as [[rituximab]] | |||
* [[Plasmapheresis]] in severe cases | |||
== Prognosis == | == Prognosis == | ||
The prognosis for individuals with CAHA varies. Some patients may experience mild symptoms, while others may have severe anemia requiring medical intervention. The condition can be chronic, with periods of remission and exacerbation. | |||
== See | == See Also == | ||
* [[Autoimmune hemolytic anemia]] | |||
* [[Warm autoimmune hemolytic anemia]] | * [[Warm autoimmune hemolytic anemia]] | ||
* [[Hemolytic anemia]] | |||
* [[Hemolytic | |||
== References == | == References == | ||
* {{Cite journal |last1=Berentsen |first1=S. |title=Cold agglutinin disease |journal=Hematology |year=2016 |volume=2016 |issue=1 |pages=226-231 |doi=10.1182/asheducation-2016.1.226}} | |||
* {{Cite book |last1=Hoffbrand |first1=A. V. |title=Hoffbrand's Essential Haematology |edition=7th |year=2016 |publisher=Wiley-Blackwell |isbn=978-1118408674}} | |||
== External Links == | |||
* [https://www.mayoclinic.org/diseases-conditions/autoimmune-hemolytic-anemia/symptoms-causes/syc-20355609 Mayo Clinic - Autoimmune Hemolytic Anemia] | |||
[[Category:Hematology]] | |||
[[Category:Autoimmune diseases]] | |||
[[Category:Blood disorders]] | [[Category:Blood disorders]] | ||
Revision as of 21:35, 27 December 2024
Cold Autoimmune Hemolytic Anemia
Cold Autoimmune Hemolytic Anemia (CAHA) is a rare type of autoimmune hemolytic anemia (AIHA) characterized by the premature destruction of red blood cells (RBCs) at low temperatures. This condition is mediated by autoantibodies that bind to RBCs, leading to their destruction by the immune system.
Pathophysiology
In CAHA, the immune system produces cold agglutinins, which are antibodies that react with RBCs at temperatures below normal body temperature, typically between 0°C and 30°C. These antibodies are usually of the IgM class and can cause RBCs to clump together (agglutinate) and be destroyed, primarily in the liver and spleen.
Symptoms
The symptoms of CAHA can vary depending on the severity of the condition and the degree of hemolysis. Common symptoms include:
Diagnosis
Diagnosis of CAHA involves several laboratory tests, including:
- Complete blood count (CBC) showing anemia
- Direct Coombs test (direct antiglobulin test) positive for complement
- Detection of cold agglutinins in the blood
- Blood smear showing agglutinated RBCs
Treatment
Treatment of CAHA focuses on managing symptoms and preventing hemolysis. Strategies include:
- Avoiding exposure to cold temperatures
- Use of immunosuppressive drugs such as rituximab
- Plasmapheresis in severe cases
Prognosis
The prognosis for individuals with CAHA varies. Some patients may experience mild symptoms, while others may have severe anemia requiring medical intervention. The condition can be chronic, with periods of remission and exacerbation.
See Also
References
- ,
Cold agglutinin disease, Hematology, 2016, Vol. 2016(Issue: 1), pp. 226-231, DOI: 10.1182/asheducation-2016.1.226,
- ,
Hoffbrand's Essential Haematology, 7th edition, Wiley-Blackwell, 2016, ISBN 978-1118408674,